Trademark: 97302599
Word
SURGERX
Status Date
Tuesday, April 23, 2024
Filing Date
Wednesday, March 9, 2022
Published for Opposition
Tuesday, February 27, 2024
5 Hydrogel for medical purposes; Natural biomaterial for delivery of immunotherapy; pharmaceutical preparations used to modulate an immune response; pharmaceutical preparations for the treatment of cancer and for enhancing immune response to tumors; therapeutic agents for impacting immune-stimulating cells; therapeutic agents for impacting immune-suppressive cells; pharmaceutical preparations for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; biological preparations for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; drug delivery agents in the form of injections for medical purposes for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations, namely, biomaterials to extend the release of immunotherapy treatments at the site of tumor resection; Natural intraoperative biomaterial for delivery of immunotherapy
10 Artificial biomaterial for delivery of immunotherapy; Artificial intraoperative biomaterial for delivery of immunotherapy
Mar 12, 2022
New Application Entered
Mar 14, 2022
New Application Office Supplied Data Entered
Jun 24, 2022
Assigned To Examiner
Jul 21, 2022
Non-Final Action Written
Jul 21, 2022
Non-Final Action E-Mailed
Jul 21, 2022
Notification Of Non-Final Action E-Mailed
Oct 21, 2022
Teas Response To Office Action Received
Oct 21, 2022
Correspondence Received In Law Office
Oct 21, 2022
Teas/Email Correspondence Entered
Nov 4, 2022
Suspension Letter Written
Nov 4, 2022
Letter Of Suspension E-Mailed
Nov 4, 2022
Notification Of Letter Of Suspension E-Mailed
Nov 4, 2022
Suspension Letter Written
Nov 4, 2022
Letter Of Suspension E-Mailed
Nov 4, 2022
Notification Of Letter Of Suspension E-Mailed
May 9, 2023
Suspension Checked - To Attorney For Action
Jun 8, 2023
Non-Final Action Written
Jun 8, 2023
Non-Final Action E-Mailed
Jun 8, 2023
Notification Of Non-Final Action E-Mailed
Aug 25, 2023
Application Extension To Response Period - Received
Aug 25, 2023
Application Extension Granted/Receipt Provided
Oct 27, 2023
Teas Change Of Owner Address Received
Oct 27, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 27, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 27, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 27, 2023
Teas Change Of Correspondence Received
Dec 7, 2023
Teas Response To Office Action Received
Dec 7, 2023
Correspondence Received In Law Office
Dec 8, 2023
Teas/Email Correspondence Entered
Jan 24, 2024
Examiners Amendment -Written
Jan 24, 2024
Examiners Amendment E-Mailed
Jan 24, 2024
Notification Of Examiners Amendment E-Mailed
Jan 24, 2024
Examiner's Amendment Entered
Jan 24, 2024
Approved For Pub - Principal Register
Feb 7, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 7, 2024
Notification Of Notice Of Publication E-Mailed
Feb 27, 2024
Published For Opposition
Mar 4, 2024
Official Gazette Publication Confirmation E-Mailed
Apr 23, 2024
Noa E-Mailed - Sou Required From Applicant
Trademark Alertz updated from USPTO on 2030-01-24
